Other Infections
CDC Immunization Committee Recommends 2 Pneumococcal Vaccines for Immunocompromised Adults
- Details
- Category: Opportunistic Illness (OIs)
- Published on Wednesday, 27 June 2012 00:00
- Written by Liz Highleyman
People with compromised immune systems, including those with advanced HIV disease, should receive a combination of 2 different vaccines to prevent pneumococcal disease, the CDC's Advisory Committee on Immunization Practices (ACIP) recommended at its meeting last week in Atlanta.
Chronic Gum Disease Linked to HPV-related Head and Neck Cancers
- Details
- Category: Human Papillomavirus (HPV)
- Published on Wednesday, 27 June 2012 00:00
- Written by Press Release
Chronic periodontitis, or inflammation of the gums, is associated with a great risk of squamous cell carcinomas of the mouth and throat that contain human papillomavirus (HPV), according to a study published in the June 18, 2012, advance online edition of Archives of Otolaryngology - Head and Neck Surgery.
Novel Antibiotic Delamanid Is Effective against Multidrug-resistant Tuberculosis
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 12 June 2012 00:00
- Written by Liz Highleyman
An experimental antibiotic drug, delamanid (OPC-67683), demonstrated good activity against highly-resistant tuberculosis (TB), clearing infection in more than 40% of participants in a Phase 2b trial, researchers reported in the June 7, 2012, New England Journal of Medicine. The drug is currently being studied in HIV positive people taking antiretroviral therapy (ART).
HHS Progress Report and HRC Health Equality Index Shed Light on LGBT Health Care
- Details
- Category: LGBT Health
- Published on Friday, 22 June 2012 00:00
- Written by Liz Highleyman
Coinciding with Gay Pride month, the Department of Health and Human Services (DHHS) this week released a progress report on health issues for gay, lesbian, bisexual, and transgender people in the U.S. In addition, the Human Right Campaign (HRC) released its latest Health Equality Index, a survey of how well health care facilities serve LGBT patients.
Daily Dark Chocolate May Reduce Cardiovascular Risk
- Details
- Category: Miscellaneous Health News
- Published on Friday, 08 June 2012 00:00
- Written by Liz Highleyman
Daily consumption of dark chocolate could significantly reduce the risk of cardiovascular events such as heart attacks, and would be cost-effective with a price tag of about $40 per person per year, according to estimates from a mathematical model reported in the May 31, 2012, British Medical Journal. The researchers stressed, however, that these benefits depend on good adherence.
Researchers Identify Origin of Cervical Cancer Caused by Human Papillomavirus
- Details
- Category: Human Papillomavirus (HPV)
- Published on Wednesday, 20 June 2012 00:00
- Written by Press Release
Researchers have identified a population of cells in the uterine cervix that appears to give rise to dysplasia and cancer caused by human papillomavirus (HPV), according to a report in the June 11, 2012, Proceedings of the National Academy of Sciences.
WHO Warns of Global Threat of Drug-resistant Gonorrhea
- Details
- Category: Other STDs
- Published on Friday, 08 June 2012 00:00
- Written by Liz Highleyman
Multidrug-resistant gonorrhea is a growing concern worldwide and millions of people may be at risk of running out of treatment options unless urgent action is taken, according to an alert issued this week by the World Health Organization (WHO).
CCR5 Inhibitors May Help Prevent Spread of Breast Cancer
- Details
- Category: Other Health News
- Published on Friday, 15 June 2012 00:00
- Written by Press Release
A class of HIV antiretroviral drugs known as CCR5 antagonists -- which includes maraviroc (Selzentry) and vicriviroc -- inhibit the invasion or spread of specific types of breast cancer cells that express CCR5 receptors, according to findings from a laboratory study published in the May 25, 2012, advance online edition of Cancer Research.
ASCO 2012: Treatment of Anal Cancer in People with HIV
- Details
- Category: Human Papillomavirus (HPV)
- Published on Tuesday, 05 June 2012 00:00
- Written by Liz Highleyman
HIV positive people may experience more aggressive anal cancer progression and require prompt diagnosis, researchers reported at the American Society of Clinical Oncology Annual Meeting (ASCO 2012) taking place this week in Chicago. A related study found that quadruple combination anal cancer therapy is safe and may be effective for both HIV positive and negative patients.
More Articles...
- Coffee Consumption Linked to Lower Risk of Death in Large Study
- Researchers Identify Compounds that May Block HPV's Ability to Cause Cancer
- March 24 is World TB Day
- WHO Releases Updated TB/HIV Guidance, Claims Nearly 1 Million Lives Saved
- CROI 2012: Community-wide Isoniazid Prevention Did Not Improve TB Control in South African Mines
Web Design and Development by